At Quotient Sciences, we can support your small molecule throughout its entire journey from discovery to product supply. For over 30 years, we have accelerated small molecule development and manufacturing to provide leading solutions for our pharmaceutical and biotechnology customers, overcoming complex scientific challenges, and maximising the opportunities and value of your product.
Our commitment and culture provide all our customers with a simple, agile and collaborative way of working. We prioritise efficiency, quality and speed of delivery, putting your product first.
Turnkey solutions for accelerating drug development are available through our integrated programs which help shorten development times to get molecules to patients faster.
Our tailored services from formulation development to clinical trial manufacturing offer comprehensive packages for each stage of the small molecule discovery and development process to commercial manufacturing.
Humanity can't afford to wait. That is why Quotient Sciences are committed to finding solutions in oncology, orphan rare and pediatrics. Fast.
At Quotient Sciences we recognise that many small molecule candidates in the pipeline today are more complex than ever before and present more challenges that we must overcome as an industry leader.
Wherever possible, we harness new technologies that complement our existing capabilities, while maximising value for our customers. As all leading pharmaceutical and biotechnology companies increasingly look to emerging technologies in their API, we constantly review and endeavour to evaluate those new technologies and increase our specialised expertise via our state-of-the-art facilities.
We will always look to accelerate our delivery timelines, cutting through silos to maximise the value we offer to our customers with the help of our flagship, integrated Translational Pharmaceutics® drug delivery platform.
We have over 30 years of experience and a successful portfolio encompassing thousands of molecules across all stages of development.